Cardinal Health Inc.
Cardinal Health Reports Strong Second Quarter Fiscal 2024 Results and Raises Guidance
Summary
Cardinal Health announced its second-quarter fiscal 2024 results, showing a 12% increase in revenue to $57.4 billion. Non-GAAP operating earnings rose 20% to $562 million, and non-GAAP diluted EPS increased 38% to $1.82. The company raised its fiscal 2024 non-GAAP EPS guidance to $7.20 to $7.35 and adjusted free cash flow guidance to approximately $2.5 billion. Additionally, Cardinal Health plans to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization.
Profitelligence Alerts
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement